Expedite™ Therapeutic Nutrional Drink for Wound Healing Key Research
Arginine and Citrulline Research
Citation |
Study Design |
Patient Population |
Groups |
Outcomes |
---|---|---|---|---|
Agarwal U, Didelija IC, Yuan Y, Wang X, Marini JC. Supplemental citrulline is more efficient than arginine in increasing systemic arginine availability in mice. 2017;147(4):596-602. doi:10.3945/jn.116.240382. |
Randomized control trial |
After recovery to presurgery body weight, 6-week-old mice were assigned to one of seven dietary treatment groups |
|
Citrulline supplementation is more efficient at increasing arginine availability than is arginine supplementation itself in mice. |
Khalaf D, Krüger M, Wehland M, Infanger M, Grimm D. The effects of oral L-arginine and L-citrulline supplementation on blood pressure. Nutrients. 2019;11(7):1679. doi:10.3390/nu11071679. |
Review |
Heterogenic study populations (small trials) |
|
Blood pressure-lowering effect was found in meta-analyses for both L-arginine and L-citrulline; more research with larger study populations is needed to confirm these results. |
Morita M, Hayashi T, Ochiai M, et al. Oral supplementation with a combination of L-citrulline and L-arginine rapidly increases plasma L-arginine concentration and enhances NO bioavailability. Biochem Biophys Res Commun. 2014;454(1):53-57. doi:10.1016/j.bbrc.2014.10.029. |
Randomized trial |
15 male rats (9 weeks old) and 9 male rabbits (8 weeks old) after 16-hour fast were given either L-citrulline, L-arginine, or a combination of each at half dosing. |
|
Combination of L-citrulline and L-arginine effectively and rapidly augments. NO-dependent responses at the acute phase. May have clinical utility for the regulation of cardiovascular function in humans. |
Shatanawi A, Momani MS, Al-Aqtash R, Hamdan MH, Gharaibeh MN. L-citrulline supplementation increases plasma nitric oxide levels and reduces arginase activity in patients with type 2 diabetes. Front Pharmacol. 2020;11:584669. doi:10.3389/fphar.2020.584669. |
Clinical study |
25 patients with type 2 diabetes on oral hypoglycemic drugs |
|
L-citrulline can have therapeutic benefits in patients with diabetes through increasing NO levels and maintaining vascular function, possibly through an arginase inhibition-related pathway. |
Wijnands KAP, Vink H, Briedé JJ, et al. Citrulline a more suitable substrate than arginine to restore NO production and the microcirculation during endotoxemia. PLoS One. 2012;7(5):e37439. doi:10.1371/journal.pone.0037439. |
Randomized trial |
65 male mice received an 18-hour IV infusion of endotoxin combined with either L-citrulline, L-arginine, or L-alanine (isonitrogenous control) during the last 6 hours; control group received sterile saline combined with L-alanine or L-citrulline during the last 6 hours |
|
L-citrulline supplementation during endotoxemia positively influenced the intestinal microvascular perfusion compared to L-arginine supplemented and control endotoxemic mice. L-citrulline supplementation (and not L-arginine supplementation) during murine endotoxemia improves the microcirculation and results in increased plasma and tissue availability of citrulline, arginine, and NO during endotoxemia. |
AUC=area under the curve, EHC=enzymatically hydrolyzed collagen hydrolysate, IV=intravenous, Pro-Hyp=prolylhydroxyproline,
Hyp-Gly=hydroxyprolylglycine, NO=nitric oxide, PUSH=Pressure Ulcer Scale for Healing, PSST=Pressure Sore Status Tool